Intracerebral accumulation of glutaric and 3‐hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl‐CoA dehydrogenase deficiency
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Glutaric acid (GA) and 3‐hydroxyglutaric acids (3‐OH‐GA) are key metabolites in glutaryl co‐enzyme A dehydrogenase (GCDH) deficiency and are both considered to be potential neurotoxins. As cerebral concentrations of GA and 3‐OH‐GA have not yet been studied systematically, we investigated the tissue‐specific distribution of these organic acids and glutarylcarnitine in brain, liver, skeletal and heart muscle of Gcdh‐deficient mice as well as in hepatic Gcdh–/– mice and in C57Bl/6 mice following intraperitoneal loading. Furthermore, we determined the flux of GA and 3‐OH‐GA across the blood–brain barrier (BBB) using porcine brain microvessel endothelial cells. Concentrations of GA, 3‐OH‐GA and glutarylcarnitine were significantly elevated in all tissues of Gcdh–/– mice. Strikingly, cerebral concentrations of GA and 3‐OH‐GA were unexpectedly high, reaching similar concentrations as those found in liver. In contrast, cerebral concentrations of these organic acids remained low in hepatic Gcdh–/– mice and after intraperitoneal injection of GA and 3‐OH‐GA. These results suggest limited flux of GA and 3‐OH‐GA across the BBB, which was supported in cultured porcine brain capillary endothelial cells. In conclusion, we propose that an intracerebral de novo synthesis and subsequent trapping of GA and 3‐OH‐GA should be considered as a biochemical risk factor for neurodegeneration in GCDH deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331 · cited 1×
“…Elvehjem system (Fisher Scientific, Schwerte, Germany) and, subsequently, homogenates were immediately snap-frozen in liquid nitrogen and stored at ) 80 C. Protein was determined according to Lowry et al. (1951) with modifications (Helenius and Simons 1972) using bovine serum albumin as a standard.”
MethodPellerin, L., & Magistretti, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10625 · Cited by 2,927 · cited 2×
“The left-hand side illustrates the astrocyte– neurone lactate shuttle hypothesis and the glutamate/glutamine (glu/ gln) cycle, demonstrating the tight coupling of excitatory (glutamatergic) neurotransmission and cerebral glucose metabolism (Magistretti et al. 1999; Pellerin and Magistretti 1994).”
BackgroundMagistretti, P. J., Pellerin, L., Rothman, D. L., & Shulman, R. G. (1999) · Science · doi:10.1126/science.283.5401.496 · Cited by 1,170 · cited 2×
“The left-hand side illustrates the astrocyte– neurone lactate shuttle hypothesis and the glutamate/glutamine (glu/ gln) cycle, demonstrating the tight coupling of excitatory (glutamatergic) neurotransmission and cerebral glucose metabolism (Magistretti et al. 1999; Pellerin and Magistretti 1994).”
BackgroundTreatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase
LINDSTEDT, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92685-9 · Cited by 631 · cited 2×
“…animals with 2-(2-N-4-trifluoromethylbenzoyl)1,3-cyclohexanedione (NTBC), which blocks an enzymatic step proximal to Fah in the tyrosine degradation pathway (i.e. 4-hydroxyphenylpyruvate dioxygenase; EC 1.13.11.27) and prevents the accumulation of the toxic metabolites (Lindstedt et al. 1992).”
BackgroundInfluentialSchulze, A., Lindner, M., Kohlmüller, D., Olgemöller, K., Mayatepek, E., & Hoffmann, G. F. (2003) · Pediatrics · doi:10.1542/peds.111.6.1399 · Cited by 519 · cited 2×
“In GCDH deficiency, increased concentrations of C5DC can be detected in plasma, dried blood spots and urine (Schulze et al. 2003; Tortorelli et al. 2005).”
BackgroundMethodSelf-citationTransporter-Mediated Permeation of Drugs Across the Blood–Brain Barrier
Tamai, I., & Tsuji, A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1371::aid-jps1>3.0.co;2-d · Cited by 363 · cited 1×
“To ensure the supply of the brain, more than 20 specific transport systems act as biochemical gatekeepers for key solutes, such as amino acids and monocarboxylic acids (Tamai and Tsuji 2000).”
BackgroundTransport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
Fellner, S., Bauer, B., Miller, D. S., Schaffrik, M., Fankhänel, M., Spruß, T., Bernhardt, G., Graeff, C., Färber, L., Gschaidmeier, H., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15451 · Cited by 359 · cited 2×
“Primary cultures of porcine BCEC were prepared as described previously (Fellner et al. 2002).”
MethodSelf-citationThe Binding of Detergents to Lipophilic and Hydrophilic Proteins
Helenius, A., & Simons, K. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45190-9 · Cited by 358 · cited 2×
“…Elvehjem system (Fisher Scientific, Schwerte, Germany) and, subsequently, homogenates were immediately snap-frozen in liquid nitrogen and stored at ) 80 C. Protein was determined according to Lowry et al. (1951) with modifications (Helenius and Simons 1972) using bovine serum albumin as a standard.”
MethodType I glutaric aciduria, part 1: Natural history of 77 patients
Strauss, K. A., Puffenberger, E. G., Robinson, D. L., & Morton, D. H. (2003) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.20007 · Cited by 325 · cited 3×
“The majority of untreated children develop severe clinical symptoms before the age of 36 months, suggesting that vulnerability is restricted to a limited period of brain development (Hoffmann et al. 1996; Strauss et al. 2003; Kyllerman et al. 2004).”
BackgroundPietz, J., Kreis, R., Rupp, A., Mayatepek, E., Rating, D., Boesch, C., & Bremer, H. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5017 · Cited by 300 · cited 2×
“This system has two weaknesses: (1) saturation of amino acid transport and competition among substrates makes the brain vulnerable to large imbalances in plasma amino acid concentrations, such as in phenylketonuria (Pietz et al. 1999); (2) pathologically increased cerebral de novo synthesis of impermeable hydrophilic…”
BackgroundBennett, J. P., Logan, W. J., & Snyder, S. H. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb06037.x · Cited by 260 · cited 2×
“…depletion of the intracellular creatine phosphate pool by 3-OH-GA (Ullrich et al. 1999); (iv) inhibition of synaptosomal glutamate uptake by GA (Bennett et al. 1973; Porciuncula et al. 2000); (v) GABA synthesis by GA and 3-OH-GA (Stokke et al. 1976); (vi) Na+/K+-ATPase by GA (Kölker et al.…”
BackgroundSweet, D. H., Chan, L. M. S., Walden, R., Yang, X.-P., Miller, D. S., & Pritchard, J. B. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00405.2002 · Cited by 220 · cited 4×
“…organic anion transporters, such as OAT3 which is predominantly expressed in proximal tubular epithelium and choroid plexus (Ohtsuki et al. 2002; Sweet et al. 2003), play a quantitative role in the efflux transport of dicarboxylic acids in general, and of GA and 3-OH-GA in particular, remains…”
BackgroundInfluentialOhtsuki, S., Asaba, H., Takanaga, H., Deguchi, T., Hosoya, K., Otagiri, M., & Terasaki, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01108.x · Cited by 219 · cited 12×
“The precursor amino acids L-lysine and L-tryptophan cross the BBB via specific transporters and, subsequently, intracerebral accumulation of glutaryl-CoA, GA and 3-OH-GA occurs as a result of GCDH deficiency and low permeability of the BBB for dicarboxylic acids; however, efflux might be mediated by organic anion tran…”
BackgroundInfluentialTrafficking between glia and neurons of TCA cycle intermediates and related metabolites
Schousboe, A., Westergaard, N., Waagepetersen, H. S., Larsson, O. M., Bakken, I. J., & Sonnewald, U. (1997) · Glia · doi:10.1002/(sici)1098-1136(199709)21:1<99::aid-glia11>3.0.co;2-w · Cited by 209 · cited 2×
“The right-hand side presents astrocytic supply of neurones with dicarboxylic TCA cycle intermediates to compensate the continuous drain of the a-ketoglutarate required for glutamate synthesis in neurones (Schousboe et al. 1997; Hassel et al. 2002).”
BackgroundBakhiya, A., Bahn, A., Burckhardt, G., & Wolff, N. (2003) · Cellular Physiology and Biochemistry · doi:10.1159/000074539 · Cited by 168 · cited 4×
“When the uptake of L-leucine was measured in the presence of increasing concentrations of L-phenylalanine, transport was apparently competitively inhibited, thus confirming our previous results (Torok et al. 1998; Bakhiya et al. 2003).”
BackgroundResultInfluentialNeonatal screening for glutaryl‐CoA dehydrogenase deficiency
Lindner, M. S., Kölker, S., Schulze, A., Christensen, E., Greenberg, C. R., & Hoffmann, G. F. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000045769.96657.af · Cited by 164 · cited 2×
“1 : 100 000 newborns in Caucasians (Lindner et al. 2004).”
Self-citationBiochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I
Koeller, D. M., Woontner, M., Crnic, L. S., Kleinschmidt-DeMasters, B. K., Stephens, J. K., Hunt, E. L., & Goodman, S. I. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.347 · Cited by 161 · cited 7×
“Therefore, Gcdh–/– mice can be considered a suitable model to investigate biochemical abnormalities in this disease confirming previous results (Koeller et al. 2002).”
BackgroundMethodResultSelf-citationNeuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort
Funk, C. B. R. (2005) · Brain · doi:10.1093/brain/awh401 · Cited by 158 · cited 5×
“Cerebral accumulation of glutaric and 3-hydroxyglutaric acids in GCDH deficiency Postmortem studies and one brain biopsy in nine patients receiving no strict and even no therapy have been published (Goodman et al. 1977; Leibel et al. 1980; Funk et al. 2005; Külkens et al. 2005).”
BackgroundType I glutaric aciduria, part 2: A model of acute striatal necrosis
Strauss, K. A., & Morton, D. H. (2003) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.20008 · Cited by 149 · cited 1×
“These results suggest that cerebral accumulation of pathologic organic acids in GCDH deficiency may not be a result of hepatic production and subsequent transport of GA and 3-OH-GA across the BBB as was previously suggested (Strauss and Morton 2003).”
BackgroundPathomechanisms of neurodegeneration in glutaryl‐CoA dehydrogenase deficiency
Kölker, S., Koeller, D. M., Okun, J. G., & Hoffmann, G. F. (2003) · Annals of Neurology · doi:10.1002/ana.10784 · Cited by 138 · cited 7×
“…et al. 1997; Ullrich et al. 1999; Kölker et al. 2000; De Mello et al. 2001; Kölker et al. 2001a,b; Kölker et al. 2002a; Latini et al. 2002; Kölker et al. 2004b; Rosa et al. 2004); (ii) inhibition of KGDHc and, to a lesser extent, pyruvate dehydrogenase complex by glutaryl-CoA (Sauer…”
BackgroundSelf-citationWang, H., Fei, Y.-J., Kekuda, R., Yang‐Feng, T. L., Devoe, L. D., Leibach, F. H., Prasad, P. D., & Ganapathy, V. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.5.c1019 · Cited by 138 · cited 2×
“1997; Hassel and Brathe 2000), it would be important to know whether either GA or 3-OH-GA also interfere with these processes, such as the transport of astrocytic TCA cycle intermediates via hNaDC3 (Wang et al. 2000).”
BackgroundMutation analysis in glutaric aciduria type I
Zschocke, J., Quak, E., Guldberg, P., & Hoffmann, G. F. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.177 · Cited by 132 · cited 1×
“2 have been described (Goodman et al. 1998; Busquets et al. 2000; Zschocke et al. 2000).”
Self-citationBioenergetics in Glutaryl-Coenzyme A Dehydrogenase Deficiency
Sauer, S. W., Okun, J. G., Schwab, M. A., Crnic, L. R., Hoffmann, G. F., Goodman, S. I., Koeller, D. M., & Kölker, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502845200 · Cited by 126 · cited 5×
“Recently, we demonstrated uncompetitive inhibition of the tricarboxylic acid cycle (TCA) enzyme complex a-ketoglutarate dehydrogenase (KGDHc) by glutaryl-CoA (Sauer et al. 2005).”
BackgroundMethodSelf-citationKikuchi, R., Kusuhara, H., Sugiyama, D., & Sugiyama, Y. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049197 · Cited by 115 · cited 4×
“…and, subsequently, intracerebral accumulation of glutaryl-CoA, GA and 3-OH-GA occurs as a result of GCDH deficiency and low permeability of the BBB for dicarboxylic acids; however, efflux might be mediated by organic anion transporters, such as OAT3 (Ohtsuki et al. 2002; Kikuchi et al. 2003).”
BackgroundInfluentialCerebral Metabolism of Lactate in Vivo: Evidence for Neuronal Pyruvate Carboxylation
Hassel, B., & Bråthe, A. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200002000-00014 · Cited by 109 · cited 2×
“As intracerebral transport of mono- and dicarboxylic acids between astrocytes and neurones is considered as particularly important for the maintenance of this energetic coupling (Schousboe et al. 1997; Hassel and Brathe 2000), it would be important to know whether either GA or 3-OH-GA also interfere with these process…”
BackgroundNeuronal Pyruvate Carboxylation Supports Formation of Transmitter Glutamate
Hassel, B., & Bråthe, A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01342.2000 · Cited by 105 · cited 1×
“…acids between astrocytes and neurones is considered as particularly important for the maintenance of this energetic coupling (Schousboe et al. 1997; Hassel and Brathe 2000), it would be important to know whether either GA or 3-OH-GA also interfere with these processes, such as the transport of…”
BackgroundPrinciples of Therapeutic Liver Repopulation
Grompe, M., Laconi, E., & Shafritz, D. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007093 · Cited by 96 · cited 2×
“The use of Fah–/– mice and the entire process of therapeutic liver repopulation via hepatocyte transplantation is reviewed by Grompe et al. (1999).”
BackgroundMethodGlutaric aciduria type I: Pathomechanisms of neurodegeneration
Ullrich, K., Flott-Rahmel, B., Schluff, P., Mußhoff, U., Das, A. M., Lücke, T., Steinfeld, R., Christensen, E., Jakobs, C., Ludolph, A. C., et al. (1999) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005595921323 · Cited by 90 · cited 6×
“We and others have demonstrated that accumulation of GA, 3-OH-GA and glutaryl-CoA interferes with cerebral energy metabolism by: (i) activation of NMDA receptors and the subsequent increase in intracellular calcium concentrations and reactive oxygen species by 3-OH-GA (Flott-Rahmel et al. 1997; Ullrich et al. 1999; Kö…”
BackgroundInfluentialKölker, S., Ahlemeyer, B., Krieglstein, J., & Hoffmann, G. F. (2001) · Pediatric Research · doi:10.1203/00006450-200107000-00015 · Cited by 89 · cited 1×
“…concentrations and reactive oxygen species by 3-OH-GA (Flott-Rahmel et al. 1997; Ullrich et al. 1999; Kölker et al. 2000; De Mello et al. 2001; Kölker et al. 2001a,b; Kölker et al. 2002a; Latini et al. 2002; Kölker et al. 2004b; Rosa et al. 2004); (ii) inhibition of KGDHc and, to a lesser…”
BackgroundSelf-citationTakakura, Y., Kuentzel, S. L., Raub, T. J., Davies, A., Baldwin, S. A., & Borchardt, R. T. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90139-y · Cited by 77 · cited 3×
“The non-metabolizable glucose analogue, 3-O-[3H]methyl-D-glucose, was used as a model substrate to study glucose transport as previously decribed (Takakura et al. 1991).”
MethodInfluentialIto, A., Ogishima, T., Ou, W., Omura, T., Aoyagi, H., Sannumn, L. E. E., Mihara, H., & Izumiya, N. (1985) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a135426 · Cited by 74 · cited 1×
“Liver mitochondria were isolated via differential centrifugation (Ito et al. 1985).”
MethodLatini, A., Rosa, R. B., Scussiato, K., Llesuy, S., Belló‐Klein, A., & Wajner, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03573-4 · Cited by 74 · cited 2×
“We and others have demonstrated that accumulation of GA, 3-OH-GA and glutaryl-CoA interferes with cerebral energy metabolism by: (i) activation of NMDA receptors and the subsequent increase in intracellular calcium concentrations and reactive oxygen species by 3-OH-GA (Flott-Rahmel et al. 1997; Ullrich et al. 1999; Kö…”
BackgroundLow Therapeutic Threshold for Hepatocyte Replacement in Murine Phenylketonuria
Hamman, K. J., Clark, H., Montini, E., Al-Dhalimy, M., Grompe, M., Finegold, M. J., & Harding, C. O. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.025 · Cited by 70 · cited 2×
“Hepatocytes were isolated from donor Gcdh mice by in situ two-step collagenase perfusion (Hamman et al. 2005).”
MethodSelf-citationKölker, S., Ahlemeyer, B., Hühne, R., Mayatepek, E., Krieglstein, J., & Hoffmann, G. F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01595.x · Cited by 68 · cited 1×
“…concentrations and reactive oxygen species by 3-OH-GA (Flott-Rahmel et al. 1997; Ullrich et al. 1999; Kölker et al. 2000; De Mello et al. 2001; Kölker et al. 2001a,b; Kölker et al. 2002a; Latini et al. 2002; Kölker et al. 2004b; Rosa et al. 2004); (ii) inhibition of KGDHc and, to a lesser…”
BackgroundSelf-citationKölker, S., Köhr, G., Ahlemeyer, B., Okun, J. G., Pawlak, V., Hörster, F., Mayatepek, E., Krieglstein, J., & Hoffmann, G. F. (2002) · Pediatric Research · doi:10.1203/00006450-200208000-00011 · Cited by 60
Self-citationGlutaric aciduria type I and kynurenine pathway metabolites: A modified hypothesis
Varadkar, S., & Surtees, R. A. H. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000045767.42193.97 · Cited by 52 · cited 1×
“Alternatively, quinolinic acid, a metabolite of the kynurenine pathway of L-tryptophan metabolism and a known agonist of NMDA receptors, has been hypothesized as a contributing factor for neurodegeneration in GCDH deficiency but this has not yet been proven (Heyes 1987; Varadkar and Surtees 2004).”
BackgroundEnzymes of Fatty Acid β‐Oxidation in Developing Brain
Reichmann, H., Maltese, W. A., & Vivo, D. C. D. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01044.x · Cited by 47 · cited 2×
“As liver tissue showed the highest specific GCDH activity (McMillan et al. 1988; Reichmann et al. 1988; Woontner et al. 2000; Koeller et al. 2002), it can be proposed that the biochemical differences of these subgroups determined in plasma and urine most likely reflect the residual hepatic GCDH…”
BackgroundHassel, B., Bråthe, A., & Petersen, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00986.x · Cited by 32 · cited 4×
“Hence, there is a restricted passage for other compounds, such as dicarboxylic acids (Hassel et al. 2002).”
BackgroundMethodInfluential
Cited by
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1
Tönjes, M., Barbus, S., Park, Y. J., Wang, W., Schlotter, M., Lindroth, A. M., Pleier, S. V., Bai, A. H. C., Karra, D., Piro, R. M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3217 · Cited by 486
Self-citationSemisynthetic sensor proteins enable metabolic assays at the point of care
Yu, Q., Xue, L., Hiblot, J., Griss, R., Fabritz, S., Roux, C., Binz, P.-A., Haas, D., Okun, J. G., & Johnsson, K. (2018) · Science · doi:10.1126/science.aat7992 · Cited by 161
Self-citationMolecular regulation of urea cycle function by the liver glucocorticoid receptor
Okun, J. G., Conway, S., Schmidt, K. V., Schumacher, J., Wang, X., de Guia, R., Zota, A., Klement, J., Seibert, O., Peters, A., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.006 · Cited by 53
Self-citation
Metadata
- Authors
- Sauer, S. W., Okun, J. G., Fricker, G., Mahringer, A., Müller, I., Crnic, L. R., Mühlhausen, C., Hoffmann, G. F., Hörster, F., Goodman, S. I., Harding, C. O., Koeller, D. M., & Kölker, S.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-03-29
- Volume
- 97
- Issue
- 3
- Pages
- 899-910
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1587210733
- Cited by
- 166
- References
- 38
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.